Pr. Pierre Coulie is a Professor at the University of Louvain and member of the Belgian Royal Academy of Medicine. He leads a research group at the de Duve Institute. He is an expert in cytotoxic responses against tumour antigens.
EFS
(Etablissement Français du Sang – French Blood Bank) transferred the PDC*vac technology to PDC*line Pharma, and provides us with privileged access to its research and GMP-compliant manufacturing infrastructures.